Kingella kingae
General medical information for education only, not medical advice. Treatment considerations summarize published guidance at drug-class level; therapy is chosen by the treating clinician using susceptibility results, local resistance patterns and current guidelines.
Overview
A Gram-negative coccobacillus that colonizes the throat of young children.
Infections
Bone and joint infection in young children; endocarditis (a HACEK organism); occasionally wound and skin infection.
Signs and symptoms
Limp, joint pain or swelling, often with mild fever.
Antibiotic and antimicrobial resistance
Some strains produce beta-lactamase.
Treatment considerations
Usually beta-lactams such as a cephalosporin, guided by susceptibility.

Sources
Sources accessed November 2026. Links open external sites that InnovexLab does not control.
Medical disclaimer
This page is general educational information summarized from published public-health and professional-society guidance. It is not medical advice, a diagnosis or a treatment recommendation, and reading it does not create a clinician–patient relationship with InnovexLab. Decisions about testing, diagnosis and treatment belong to the treating clinician, using the patient’s history and examination, laboratory and susceptibility results, local resistance patterns and current guidelines. Guidance changes over time; consult the original sources for the latest version. InnovexLab provides this information as is and does not warrant that it is complete or current.
Patients with questions about their health should contact their own healthcare provider. In an emergency, call 911.